Tempus
Business Services · Illinois, United States · 2,300 Employees
View Company Info for Free
About
Headquarters
600 W Chicago Ave Ste 510, Chicago, Illinois, 6...Phone Number
(833) 514-4187Website
www.tempus.comRevenue
$595.6 MillionStock Symbol
TEMIndustry
Most Recent Scoops
Highlights
$1.8B
Total Funding Amount
$410.7M
Most Recent Funding Amount
11
Number of Funding Rounds
Who is Tempus
Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molec ular data. We enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through our analytical machine learning platform that uses the power of artificial intelligence in healthcare. We also work with partners to facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets.Read more
Popular SearchesTempus AI IncTempusTempus IncTempus LLCTempus Labs IncSIC Code 87,873NAICS Code 54,541Ticker NASDAQ:TEMShow moreTempus Org Chart
Is Tempus your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Tempus, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Tempus launches new products
Click to see if Tempus had a recent Job posting/layoffs
Earning: See what the market has to say on Tempus recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Tempus
Check out if Tempus is spiking on competitors!
Check if Tempus has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Tempus has new funding data
Recommended Actions
Find VP level buyers at Tempus
Find 2 more new buyers
Similar Companies to Tempus
Analyze insights from companies similar to Tempus and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Flatiron2,500$525.1M
- Innovaccer1,200$252.1M
- 10x Genomics1,259$631.7M
- Ambry Genetics750$253.2M
- Health Catalyst1,300$299.5M
- Guardant Health1,768$643.8M
- Palantir3,689$2.3B
- MEDITECH3,508$736.9M
More similar companies
Tempus financials insights
Gather financial insights about Tempus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Tempus Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Tempus Tech Stack
A closer look at the technologies used by Tempus
Most Recent Scoops
Tempus News & Media
Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced four abstracts were accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2024, which convenes in Barcelona, Spain, from September 13-17, 2024. "ESMO provides a great platform to share our recent research and advancements with the global oncology community, foster further collaboration, and driveTempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the beta launch of a patient-facing app, olivia, an AI-enabled personal health concierge to empower individuals to holistically organize, manage, and proactively take control of their own health data. olivia, which is currently only available to beta users, leverages generative AI to provide patients and their caregivers personaTempus Announces Real World Data Collaboration with BioNTech
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM, “Tempus”), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a multi-year collaboration with BioNTech SE (Nasdaq: BNTX, “BioNTech”), a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. This collaboration leverages Tempus' robust multimodal datasets in support of BioNTech’s next-generation oncology pipeline. Under thisTempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4th, held in New York, NY. Tempus Founder and CEO, Eric Lefkofsky, will speak in a fireside discussion at the conference on Wednesday, September 4, 2024 at 8:30 a.m. ET. About Tempus Tempus is a technology company advancing precision medicine
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Tempus
Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. We enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through our analytical machine learning platform that uses the po... Read More